Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT03766828
Collaborator
(none)
36
1
21.9
1.6

Study Details

Study Description

Brief Summary

A unique inside-out-access technique with a new CE certified device (Surfacer (R) Bluegrass Vascular, San Antonio, Tx, USA) enables repetitive and confident right-sided placement of central venous catheters in hemodialysis patients with thoracic central venous occlusion.

Condition or Disease Intervention/Treatment Phase
  • Procedure: inside-out-access technique with inside-out access device (Surfacer (R))
  • Procedure: access technique including Sharp recanalization

Study Design

Study Type:
Observational
Actual Enrollment :
36 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
Actual Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Jun 30, 2018
Actual Study Completion Date :
Jun 30, 2018

Arms and Interventions

Arm Intervention/Treatment
inside-out-access technique with inside-out access device

Procedure: inside-out-access technique with inside-out access device (Surfacer (R))
inside-out-access technique with (Surfacer (R)) with a new CE certified device (Surfacer (R), Bluegrass Vascular)

access technique including Sharp recanalization

Procedure: access technique including Sharp recanalization
access technique with Sharp recanalization via interventional radiology

Outcome Measures

Primary Outcome Measures

  1. Achievement of dialysis access [1 day]

Secondary Outcome Measures

  1. procedure related complications [3 months]

    infections, bleeding, hematoma or pericardial effusions and intervention related parameters

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with thoracic central venous occlusion
Exclusion Criteria:
  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna Vienna Austria 1180

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

  • Principal Investigator: Gürkan Sengölge, Department of Medicine III, Division of Nephrology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guerkan SENGOELGE, Assoc. Prof. Priv.-Doz. Dr., Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT03766828
Other Study ID Numbers:
  • Vienna-DialysisAccess
First Posted:
Dec 6, 2018
Last Update Posted:
May 29, 2019
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guerkan SENGOELGE, Assoc. Prof. Priv.-Doz. Dr., Medical University of Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 29, 2019